{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:21:47Z","timestamp":1787242907821,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","funder":[{"DOI":"10.13039\/501100005712","name":"Deanship of scientific research of Jordan","doi-asserted-by":"publisher","award":["20172018-117"],"award-info":[{"award-number":["20172018-117"]}],"id":[{"id":"10.13039\/501100005712","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2020,12,31]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study aims to identify the changes in expression of hypoxia-inducible genes in seven different cancer cell\nlines that vary in their oxygen levels in an attempt to identify hypoxia biomarkers that can be targeted in therapy. Profiling of hypoxia\ninducible-gene expression of these different cancer cell lines can be used as a baseline data for further studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Human cancer cell lines obtained from the American Type Culture Collection were used; MCF7 breast cancer cells, PANC1 pancreatic cancer cells, PC-3 prostate cancer cells, SH-SY5Y neuroblastoma brain cancer cells, A549 lung cancer cells, and HEPG2\nhepatocellular carcinoma. In addition, we used MCF10A non-tumorigenic human breast epithelial cell line as a normal cell line. The\ndifferences in gene expression were examined using real-time PCR array (PAHS-032Z, Human Hypoxia Signaling Pathway PCR\nArray) and analyzed using the \u0394\u0394Ct method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Almost all hypoxia-inducible genes showed a PO2-dependent up- and down-regulated expression. Noticeable gene expression differences were identified. The most important changes occurred in the HIF1\u03b1 and NF-KB signaling pathways targeted genes\nand in central carbon metabolism pathway genes such as HKs, PFKL, and solute transporters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study identified possible hypoxia biomarkers genes such as NF-KB, HIF1\u03b1, HK, PFKL, and PIM1 that were expressed in all hypoxic cells. Pleotropic pathways that play a role in inducing hypoxia directly such as HIF1 \u03b1 and NF-kB pathways\nwere upregulated. In addition, genes expressed only in the severe hypoxic liver and pancreatic cells indicate that severe and intermediate hypoxic cancer cells vary in their gene expression. Gene expression differences between cancer and normal cells showed the\nshift in gene expression profile to survive and proliferate under hypoxia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1874467213666200521081653","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T11:38:44Z","timestamp":1590061124000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Determining the Relative Gene Expression Level of Hypoxia Related Genes in Different Cancer Cell Lines"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0650-3448","authenticated-orcid":true,"given":"Laila","family":"Baqlouq","sequence":"first","affiliation":[{"name":"Department of Biology, Faculty of Science, The University of Jordan, Amman 11942, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8005-3908","authenticated-orcid":true,"given":"Malek","family":"Zihlif","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, The University of Jordan, Amman 11942, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3130-1749","authenticated-orcid":true,"given":"Hana","family":"Hammad","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Science, The University of Jordan, Amman 11942, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3054-4047","authenticated-orcid":true,"given":"Tuqa M. Abu","family":"Thaib","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, The University of Jordan, Amman 11942, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"Hanahan D.","year":"2000","unstructured":"Hanahan D.; Weinberg R.A.; The hallmarks of cancer. Cell 2000,100(1),57-70","journal-title":"Cell"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1371\/journal.pmed.0030047","volume":"3","author":"Chi J-T.","year":"2006","unstructured":"Chi J-T.; Wang Z.; Nuyten D.S.A.; Rodriguez E.H.; Schaner M.E.; Salim A.; Wang Y.; Kristensen G.B.; Helland A.; B\u00f8rresen-Dale A-L.; Giaccia A.; Longaker M.T.; Hastie T.; Yang G.P.; van de Vijver M.J.; Brown P.O.; Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 2006,3(3),e47-e47","journal-title":"PLoS Med"},{"key":"ref=3","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20130676","volume":"87","author":"McKeown S.R.","year":"2014","unstructured":"McKeown S.R.; Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol 2014,87(1035)","journal-title":"Br J Radiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"13595","DOI":"10.1074\/jbc.C200694200","volume":"278","author":"Chen D.","year":"2003","unstructured":"Chen D.; Li M.; Luo J.; Gu W.; Direct interactions between HIF-1 \u03b1 and Mdm2 modulate p53 function. J Biol Chem 2003,278(16),13595-13598","journal-title":"J Biol Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/nature04695","volume":"440","author":"Erler J.T.","year":"2006","unstructured":"Erler J.T.; Bennewith K.L.; Nicolau M.; Dornh\u00f6fer N.; Kong C.; Le Q-T.; Chi J-T.A.; Jeffrey S.S.; Giaccia A.J.; Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 2006,440(7088),1222-1226","journal-title":"Nature"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2174\/156652409788167113","volume":"9","author":"Kim Y.","year":"2009","unstructured":"Kim Y.; Lin Q.; Glazer P.M.; Yun Z.; Hypoxic tumor microenvironment and cancer cell differentiation. Curr Mol Med 2009,9(4),425-434","journal-title":"Curr Mol Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"11429","DOI":"10.1158\/0008-5472.CAN-05-1274","volume":"65","author":"Payne S.L.","year":"2005","unstructured":"Payne S.L.; Fogelgren B.; Hess A.R.; Seftor E.A.; Wiley E.L.; Fong S.F.; Csiszar K.; Hendrix M.J.; Kirschmann D.A.; Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res 2005,65(24),11429-11436","journal-title":"Cancer Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-3-319-77736-8_9","author":"Antonio M.J.","year":"2018","unstructured":"Antonio M.J.; Le A.;  The Heterogeneity of Cancer Metabolism 2018,119-129","journal-title":"The Heterogeneity of Cancer Metabolism"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1634\/theoncologist.9-90005-4","volume":"9","author":"Vaupel P.","year":"2004","unstructured":"Vaupel P.; Harrison L.; Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 2004,9(Suppl. 5),4-9","journal-title":"Oncologist"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0753-3322(03)00098-2","volume":"57","author":"Bando H.","year":"2003","unstructured":"Bando H.; Toi M.; Kitada K.; Koike M.; Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231. Biomed Pharmacother 2003,57(8),333-340","journal-title":"Biomed Pharmacother"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"Huang W.","year":"2009","unstructured":"Huang W.; Sherman B.T.; Lempicki R.A.; Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009,4(1),44-57","journal-title":"Nat Protoc"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"Hanahan D.","year":"2011","unstructured":"Hanahan D.; Weinberg R. A.; Hallmarks of cancer: the next generation. cell 2011,144(5),646-674.","journal-title":"cell"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/cdd.2014.173","volume":"22","author":"Roberts D.J.","year":"2015","unstructured":"Roberts D.J.; Miyamoto S.; Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy. Cell Death Differ 2015,22(2),248-257","journal-title":"Cell Death Differ"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"Wang M.","year":"2017","unstructured":"Wang M.; Zhao J.; Zhang L.; Wei F.; Lian Y.; Wu Y.; Gong Z.; Zhang S.; Zhou J.; Cao K.; Li X.; Xiong W.; Li G.; Zeng Z.; Guo C.; Role of tumor microenvironment in tumorigenesis. J Cancer 2017,8(5),761-773","journal-title":"J Cancer"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098756","volume":"9","author":"Mulukutla B.C.","year":"2014","unstructured":"Mulukutla B.C.; Yongky A.; Daoutidis P.; Hu W-S.; Bistability in glycolysis pathway as a physiological switch in energy metabolism. PLoS One 2014,9(6)","journal-title":"PLoS One"},{"key":"ref=16","first-page":"473","volume":"6","author":"Yang J.","year":"2016","unstructured":"Yang J.; Li J.; Le Y.; Zhou C.; Zhang S.; Gong Z.; PFKL\/miR-128 axis regulates glycolysis by inhibiting AKT phosphorylation and predicts poor survival in lung cancer. Am J Cancer Res 2016,6(2),473-485","journal-title":"Am J Cancer Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"10386","DOI":"10.1073\/pnas.151257998","volume":"98","author":"Biswas D.K.","year":"2001","unstructured":"Biswas D.K.; Dai S-C.; Cruz A.; Weiser B.; Graner E.; Pardee A.B.; The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci USA 2001,98(18),10386-10391","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1158\/1078-0432.CCR-05-2800","volume":"12","author":"Van Laere S.J.","year":"2006","unstructured":"Van Laere S.J.; Van der Auwera I.; Van den Eynden G.G.; Elst H.J.; Weyler J.; Harris A.L.; van Dam P.; Van Marck E.A.; Vermeulen P.B.; Dirix L.Y.; Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding. Clin Cancer Res 2006,12(11 Pt 1),3249-3256","journal-title":"Clin Cancer Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cancergencyto.2009.01.017","volume":"191","author":"Zhang P.","year":"2009","unstructured":"Zhang P.; Wei Q.; Li X.; Wang K.; Zeng H.; Bu H.; Li H.; A functional insertion\/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer. Cancer Genet Cytogenet 2009,191(2),73-77","journal-title":"Cancer Genet Cytogenet"},{"key":"ref=20","first-page":"302","volume":"8","author":"Xiong S.","year":"2018","unstructured":"Xiong S.; Wang R.; Chen Q.; Luo J.; Wang J.; Zhao Z.; Li Y.; Wang Y.; Wang X.; Cheng B.; Cancer-associated fibroblasts promote stem cell-like properties of hepatocellular carcinoma cells through IL-6\/STAT3\/Notch signaling. Am J Cancer Res 2018,8(2),302-316","journal-title":"Am J Cancer Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"9409","DOI":"10.18632\/oncotarget.3352","volume":"6","author":"Jiang Y.","year":"2015","unstructured":"Jiang Y.; Zhu Y.; Wang X.; Gong J.; Hu C.; Guo B.; Zhu B.; Li Y.; Temporal regulation of HIF-1 and NF-\u03baB in hypoxic hepatocarcinoma cells. Oncotarget 2015,6(11),9409-9419","journal-title":"Oncotarget"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"48755","DOI":"10.18632\/oncotarget.17835","volume":"8","author":"Zhou Y.","year":"2017","unstructured":"Zhou Y.; Chu X.; Deng F.; Tong L.; Tong G.; Yi Y.; Liu J.; Tang J.; Tang Y.; Xia Y.; Dai Y.; The adenosine A2b receptor promotes tumor progression of bladder urothelial carcinoma by enhancing MAPK signaling pathway. Oncotarget 2017,8(30),48755-48768","journal-title":"Oncotarget"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1593\/neo.08478","volume":"10","author":"Ryzhov S.","year":"2008","unstructured":"Ryzhov S.; Novitskiy S.V.; Zaynagetdinov R.; Goldstein A.E.; Carbone D.P.; Biaggioni I.; Dikov M.M.; Feoktistov I.; Host A(2B) adenosine receptors promote carcinoma growth. Neoplasia 2008,10(9),987-995","journal-title":"Neoplasia"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"e1606","DOI":"10.1038\/cddis.2014.558","volume":"6","author":"Jung H.","year":"2015","unstructured":"Jung H.; Kim J.S.; Kim W.K.; Oh K.J.; Kim J.M.; Lee H.J.; Han B.S.; Kim D.S.; Seo Y-S.; Lee S.C.; Park S.G.; Bae K.H.; Intracellular annexin A2 regulates NF-\u03baB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer. Cell Death Dis 2015,6(1),e1606-e1606","journal-title":"Cell Death Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12307-011-0064-9","volume":"4","author":"Lokman N.A.","year":"2011","unstructured":"Lokman N.A.; Ween M.P.; Oehler M.K.; Ricciardelli C.; The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron 2011,4(2),199-208","journal-title":"Cancer Microenviron"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10549-016-3820-1","volume":"157","author":"Wise R.","year":"2016","unstructured":"Wise R.; Duhachek-Muggy S.; Qi Y.; Zolkiewski M.; Zolkiewska A.; Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cells. Breast Cancer Res Treat 2016,157(2),241-252","journal-title":"Breast Cancer Res Treat"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"8512","DOI":"10.18632\/oncotarget.14337","volume":"8","author":"Xia W.","year":"2017","unstructured":"Xia W.; Zhuang J.; Wang G.; Ni J.; Wang J.; Ye Y.; P4HB promotes HCC tumorigenesis through downregulation of GRP78 and subsequent upregulation of epithelial-to-mesenchymal transition. Oncotarget 2017,8(5),8512-8521","journal-title":"Oncotarget"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1517\/13543784.2012.668527","volume":"21","author":"Merkel A.L.","year":"2012","unstructured":"Merkel A.L.; Meggers E.; Ocker M.; PIM1 kinase as a target for cancer therapy. Expert Opin Investig Drugs 2012,21(4),425-436","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/cdd.2009.174","volume":"17","author":"Nihira K.","year":"2010","unstructured":"Nihira K.; Ando Y.; Yamaguchi T.; Kagami Y.; Miki Y.; Yoshida K.; Pim-1 controls NF-kappaB signalling by stabilizing RelA\/p65. Cell Death Differ 2010,17(4),689-698","journal-title":"Cell Death Differ"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"744","DOI":"10.4049\/jimmunol.168.2.744","volume":"168","author":"Zhu N.","year":"2002","unstructured":"Zhu N.; Ramirez L.M.; Lee R.L.; Magnuson N.S.; Bishop G.A.; Gold M.R.; CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-\u03ba B pathway. J Immunol 2002,168(2),744-754","journal-title":"J Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.1128\/MCB.25.14.5834-5845.2005","volume":"25","author":"Sofer A.","year":"2005","unstructured":"Sofer A.; Lei K.; Johannessen C.M.; Ellisen L.W.; Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 2005,25(14),5834-5845","journal-title":"Mol Cell Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"32512","DOI":"10.1074\/jbc.M112.351957","volume":"287","author":"Wang C-Y.","year":"2012","unstructured":"Wang C-Y.; Chen C-L.; Tseng Y-L.; Fang Y-T.; Lin Y-S.; Su W-C.; Chen C-C.; Chang K-C.; Wang Y-C.; Lin C-F.; Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms. J Biol Chem 2012,287(39),32512-32524","journal-title":"J Biol Chem"},{"key":"ref=33","author":"Whatcott C.J.","year":"2012","unstructured":"Whatcott C.J.; Posner R.G.; Von Hoff D.D.; Han H.;  Pancreatic Cancer and Tumor Microenvironment 2012","journal-title":"Pancreatic Cancer and Tumor Microenvironment"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.regpep.2005.09.026","volume":"133","author":"Abasolo I.","year":"2006","unstructured":"Abasolo I.; Montuenga L.M.; Calvo A.; Adrenomedullin prevents apoptosis in prostate cancer cells. Regul Pept 2006,133(1-3),115-122","journal-title":"Regul Pept"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/hep.24479","volume":"54","author":"Li H.","year":"2011","unstructured":"Li H.; Ge C.; Zhao F.; Yan M.; Hu C.; Jia D.; Tian H.; Zhu M.; Chen T.; Jiang G.; Xie H.; Cui Y.; Gu J.; Tu H.; He X.; Yao M.; Liu Y.; Li J.; Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1\/integrin \u03b21 signaling in human hepatocellular carcinoma. Hepatology 2011,54(3),910-919","journal-title":"Hepatology"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.molonc.2016.05.004","volume":"10","author":"Kirby M.K.","year":"2016","unstructured":"Kirby M.K.; Ramaker R.C.; Gertz J.; Davis N.S.; Johnston B.E.; Oliver P.G.; Sexton K.C.; Greeno E.W.; Christein J.D.; Heslin M.J.; Posey J.A.; Grizzle W.E.; Vickers S.M.; Buchsbaum D.J.; Cooper S.J.; Myers R.M.; RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4. Mol Oncol 2016,10(8),1169-1182","journal-title":"Mol Oncol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1210\/me.2007-0298","volume":"22","author":"Hwang-Verslues W.W.","year":"2008","unstructured":"Hwang-Verslues W.W.; Sladek F.M.; Nuclear receptor hepatocyte nuclear factor 4\u03b11 competes with oncoprotein c-Myc for control of the p21\/WAF1 promoter. Mol Endocrinol 2008,22(1),78-90","journal-title":"Mol Endocrinol"},{"key":"ref=38","first-page":"167","volume":"32","author":"Lazarevich N.L.","year":"2010","unstructured":"Lazarevich N.L.; Shavochkina D.A.; Fleishman D.I.; Kustova I.F.; Morozova O.V.; Chuchuev E.S.; Patyutko Y.I.; Deregulation of hepatocyte nuclear factor 4 (HNF4)as a marker of epithelial tumors progression. Exp Oncol 2010,32(3),167-171","journal-title":"Exp Oncol"}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/182173","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/182173\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/182173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T18:57:00Z","timestamp":1746557820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/182173\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467213666200521081653","relation":{},"ISSN":["1874-4672"],"issn-type":[{"value":"1874-4672","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}